The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Crossref DOI link: https://doi.org/10.1245/s10434-015-4962-9
Published Online: 2015-11-16
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kusamura, Shigeki
Torres Mesa, Pilar Adriana
Cabras, Antonello
Baratti, Dario
Deraco, Marcello
Funding for this research was provided by:
AIRC (ASSOCIAZIONE ITALIANA PER LA RICERCA SU CANCRO) (AIRC-2013-144445)
Text and Data Mining valid from 2015-11-16